Scientists from St. Jude Children's Research Hospital, Seattle Children's and the Children's Oncology Group (COG) have identified novel genetic variations that influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood cancer.
New genomic predictors of relapse in childhood B-cell acute lymphoblastic leukemia uncovered
- Thread starter Educator
- Start date